CBP 200 (Spectracef 200 mg)
Generic Name: cefditoren
Pill imprint CBP 200 has been identified as Spectracef 200 mg.
Spectracef is used in the treatment of skin and structure infection; skin or soft tissue infection; pneumonia; tonsillitis/pharyngitis; bronchitis and belongs to the drug class third generation cephalosporins. There is no proven risk in humans during pregnancy. Spectracef 200 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- cefditoren
- Imprint:
- CBP 200
- Strength:
- 200 mg
- Color:
- White
- Size:
- 17.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Third generation cephalosporins
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Cornerstone BioPharma Inc
- National Drug Code (NDC):
- 10122-0801
- Inactive Ingredients:
- carnauba wax
croscarmellose sodium
D&C Red No. 27
mannitol
hydroxypropyl cellulose
hypromelloses
magnesium stearate
polyethylene glycol
propylene glycol
shellac
sodium caseinate
sodium tripolyphosphate
titanium dioxide
FD&C Blue No. 1
| NDC Code | Manufacturer / Repackager |
|---|---|
| 24486-0801 | Aristos Pharmaceuticals Inc |
Note: Inactive ingredients may vary.
More about Spectracef (cefditoren)
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
